Schonfeld Strategic Advisors LLC Arcutis Biotherapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $15.2 Billion
  • Q3 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 189,555 shares of ARQT stock, worth $4.74 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
189,555
Previous 520,284 63.57%
Holding current value
$4.74 Million
Previous $7.29 Million 51.01%
% of portfolio
0.02%
Previous 0.06%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$13.39 - $18.85 $4.43 Million - $6.23 Million
-330,729 Reduced 63.57%
189,555 $3.57 Million
Q2 2025

Aug 14, 2025
BUY
$12.59 - $16.6 $6.32 Million - $8.33 Million
501,818 Added 2717.52%
520,284 $7.29 Million
Q1 2025

May 15, 2025
SELL
$11.4 - $17.29 $51,687 - $78,392
-4,534 Reduced 19.71%
18,466 $288,000
Q4 2024

Feb 14, 2025
SELL
$8.31 - $14.99 $61,070 - $110,161
-7,349 Reduced 24.21%
23,000 $320,000
Q3 2024

Nov 14, 2024
BUY
$8.32 - $11.0 $117,936 - $155,925
14,175 Added 87.64%
30,349 $282,000
Q2 2024

Aug 14, 2024
BUY
$7.24 - $12.53 $117,099 - $202,660
16,174 New
16,174 $150,000
Q4 2022

Feb 14, 2023
BUY
$13.96 - $20.4 $392,276 - $573,240
28,100 New
28,100 $415,000
Q2 2022

Aug 15, 2022
SELL
$16.33 - $22.2 $293,874 - $399,511
-17,996 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$14.38 - $22.79 $258,782 - $410,128
17,996 New
17,996 $347,000

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $1.5B
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email